(Q43514403)

24 November 2017

title

Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy (English)

1 reference

24 November 2017

Wei-Feng Peng

1

1 reference

24 November 2017

Jing Ding

2

1 reference

24 November 2017

Ling-Yan Mao

3

1 reference

24 November 2017

Xin Li

4

1 reference

24 November 2017

Liang Liang

5

1 reference

24 November 2017

Cai-Zhong Chen

6

1 reference

24 November 2017

Wei-Zhong Cheng

7

1 reference

24 November 2017

Wei Fan

8

1 reference

24 November 2017

Xin Wang

9

1 reference

24 November 2017

publication date

20 August 2013

1 reference

24 November 2017

1 reference

24 November 2017

volume

29

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

144-149

1 reference

Depression and comorbidity in community-based patients with epilepsy or asthma.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

The influence of comorbid depression on quality of life for people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Sociodemographic and clinical factors associated with depression in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Ipsilateral and contralateral MRI volumetric abnormalities in chronic unilateral temporal lobe epilepsy and their clinical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Temporal lobe epilepsy, depression, and hippocampal volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

An update on the role of glutamate in the pathophysiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Glutamate and depression: clinical and preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Validity and reliability of the Chinese Hamilton Depression Rating Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Depression in epilepsy: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Gender differences in depression. Critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Epilepsy & depression: the effects of comorbidity on hippocampal volume--a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Multi-voxel magnetic resonance spectroscopy at 3T in patients with idiopathic generalised epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

Current treatments of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.07.004

10.1016/J.YEBEH.2013.07.004

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference